摘要
癌症干细胞(CSCs)构成了肿瘤细胞的一个亚群,具有自我更新和肿瘤启动能力,并能够产生构成肿瘤的癌细胞的异质谱系。CSCs对几乎所有的传统癌症治疗都表现出内在的耐药性机制,使它们能够在当前的癌症治疗中存活下来,并启动肿瘤的复发和转移。赋予CSCs抗性和存活的不同途径和机制,包括激活Wnt/βcatenin、Sonic刺猬、Notch、PI3K/Akt/mTOR和STAT3信号通路、醛脱氢酶1(ALDH1)和致癌microrna的表达,以及上皮-间充质转化(EMT)的获得。某些植物化学物质,特别是姜黄素、表没食子儿茶素-3加仑酸盐(EGCG)、硫胺、白藜芦醇和染料木素已被证明在体外和人类异种移植小鼠中干扰这些内在的CSC途径,导致CSC的消除。此外,最近的临床试验已经证明了五种植物化学物质的疗效,单独或与现代癌症疗法联合治疗,以及对各种类型的癌症。由于目前的癌症治疗未能根除CSCs,导致癌症复发和进展,靶向肿瘤干细胞与姜黄素、EGCG、亚砜、白藜芦醇和染料木素,结合和/或结合传统的细胞毒性药物和新的癌症治疗,可能提供一种新的癌症治疗策略。
关键词: 姜黄素、EGCG、硫胺、白藜芦醇、染料木素、植物化学物质,癌症干细胞。
Current Medicinal Chemistry
Title:The “Big Five” Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein
Volume: 28 Issue: 22
关键词: 姜黄素、EGCG、硫胺、白藜芦醇、染料木素、植物化学物质,癌症干细胞。
摘要: Cancer stem cells (CSCs) constitute a subpopulation of tumor cells that possess self-renewal and tumor initiation capacity, and the ability to give rise to the heterogeneous lineages of cancer cells that comprise the tumor. CSCs exhibit intrinsic mechanisms of resistance to virtually all conventional cancer therapeutics, allowing them to survive current cancer therapies and to initiate tumor recurrence and metastasis. Different pathways and mechanisms that confer resistance and survival of CSCs, including activation of the Wnt/β- catenin, Sonic Hedgehog, Notch, PI3K/Akt/mTOR and STAT3 signaling pathways, expression of aldehyde dehydrogenase 1 (ALDH1) and oncogenic microRNAs, and acquisition of epithelial-mesenchymal transition (EMT), have been identified recently. Certain phytochemicals, in particular curcumin, epigallocatechin-3-gallate (EGCG), sulforaphane, resveratrol and genistein have been shown to interfere with these intrinsic CSC pathways in vitro and in human xenograft mice, leading to elimination of CSCs. Moreover, recent clinical trials have demonstrated the therapeutic efficacy of five phytochemicals, alone or in combination with modern cancer therapeutics, and in various types of cancer. Since current cancer therapies fail to eradicate CSCs, leading to cancer recurrence and progression, targeting of CSCs with phytochemicals such as curcumin, EGCG, sulforaphane, resveratrol and genistein, combined with each other and/or in combination with conventional cytotoxic drugs and novel cancer therapeutics, may offer a novel therapeutic strategy against cancer.
Export Options
About this article
Cite this article as:
The “Big Five” Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein, Current Medicinal Chemistry 2021; 28 (22) . https://dx.doi.org/10.2174/0929867327666200228110738
DOI https://dx.doi.org/10.2174/0929867327666200228110738 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Eggshell Membrane Based Turmeric Extract Loaded Orally Disintegrating
Films
Current Drug Delivery Recent Developments in Polymeric Nanoparticle Engineering and Their Applications in Experimental and Clinical Oncology
Anti-Cancer Agents in Medicinal Chemistry Leveraging Structural Diversity and Allosteric Regulatory Mechanisms of Protein Kinases in the Discovery of Small Molecule Inhibitors
Current Medicinal Chemistry Design, Synthesis and Mode of Action of Some New 2-(4'-aminophenyl) benzothiazole Derivatives as Potent Antimicrobial Agents
Letters in Drug Design & Discovery Paclitaxel Formulations: Challenges and Novel Delivery Options
Current Drug Delivery The Disposal of Reactive Carbonyl Species through Carnosine Conjugation: What We Know Now
Current Medicinal Chemistry HIV-1 Matrix Protein p17 and its Receptors
Current Drug Targets Chronic Hypoxia Potentiates Age-Related Oxidative Imbalance in Brain Vessels and Synaptosomes
Current Neurovascular Research Solubility Enhancement and Delivery Systems of Curcumin a Herbal Medicine: A Review
Current Drug Delivery A Review of Methods and Tools for Database Integration in Biomedicine
Current Bioinformatics High Content, Multi-Parameter Analyses in Buccal Cells to Identify Alzheimer’s Disease
Current Alzheimer Research Bioactivity of Turmeric-derived Curcuminoids and Related Metabolites in Breast Cancer
Current Pharmaceutical Design Geldanamycin, Radicicol, and Chimeric Inhibitors of the Hsp90 Nterminal ATP Binding Site
Current Topics in Medicinal Chemistry Nanotechnologies: A Strategy to Overcome Blood-Brain Barrier
Current Drug Metabolism Activated Carbon/MoO<sub>3</sub>: Efficient Catalyst for Green Synthesis of Chromeno[<i>d</i>]pyrimidinediones and Xanthenones
Combinatorial Chemistry & High Throughput Screening Biomarkers for Colorectal Cancer: Identification Through Proteomics
Current Proteomics A Study on the Biological Activity of 2-thioxo-imidazolidin-4-ones
Letters in Drug Design & Discovery Recent Advances in Design of Potential Quinoxaline Anti-Infectives
Current Medicinal Chemistry Effect of Drugs in Cells and Tissues by NMR Spectroscopy
Current Topics in Medicinal Chemistry Compounds Combining Aminoadamantane and Monoterpene Moieties: Cytotoxicity and Mutagenic Effects
Medicinal Chemistry